Skip to main content

Kapsch TrafficCom selects TomTom Traffic to enhance its global traffic management solutions

AMSTERDAM, March 11, 2026 (GLOBE NEWSWIRE) — TomTom (TOM2), the specialist in mapping and location technology, today announced that Kapsch TrafficCom (KTCG), a global leader in traffic management and tolling solutions, has selected TomTom Traffic to power the next generation of its intelligent mobility offerings. By integrating TomTom’s advanced traffic data and services, Kapsch TrafficCom will expand and strengthen its end‑to‑end portfolio, enabling public authorities and road operators worldwide to make more accurate, data-driven decisions.Through the partnership, Kapsch TrafficCom will integrate TomTom’s Floating Car Data (FCD) and traffic services directly into its EcoTrafiX Platform, an end‑to‑end traffic management system trusted by cities and road authorities worldwide. This integration provides users with immediate access...

Continue reading

Wereldhave, through Wereldhave Belgium, acquires supermarket unit and completes ownership of shopping center Ville2 in Charleroi

Wereldhave Belgium has reached an agreement with Equilis, acting on behalf of Fidagh SA, to acquire a supermarket anchor unit in shopping center Ville2 in Charleroi with a total gross lettable area of 2.712 m². Following the acquisition, the Wereldhave group will own 100% of the shopping center. The acquisition by Wereldhave Belgium is financed in cooperation with Wereldhave N.V. through a contribution in kind, whereby the seller will receive 263,061 in newly issued Wereldhave N.V. shares. The shares are issued at market value, underlining investor confidence. The transaction will have a slightly positive impact on the group’s Loan-to-Value (LTV) ratio, reducing the pro forma LTV by 10 basis points from 42.5% to 42.4% based on the figures as at year-end 2025. About Ville2 in CharleroiVille2 is a prime mixed-use shopping center with approximately...

Continue reading

Elis: Full-year 2025 results

Record financial performance in 2025 Further improvement of financial metrics expected in 2026 Share buyback program of up to 500 million euros in 2026 2025 key figures: all financial indicators at record highsRevenue of 4,796.8 million euros, up +5.5% at constant exchange rates (+3.8% on an organic basis) Adjusted EBITDA up 5.6% to 1,700.1 million euros Adjusted EBITDA margin at 35.4%, up 20 bps Adjusted EBIT up 4.6% to 766.6 million euros Adjusted EBIT margin stable at 16.0% of revenue Net income up 8.6% at 366.6 million euros Headline net income up 4.7% at 467.3 million euros Headline net income per share up 5.2% to 1.85 euros (on a fully diluted basis) Free cash flow at 358.6 million euros, up 3.5% Financial leverage ratio at 1.75x as of December 31, 2025, down 0.1x compared to December 31, 20242025 business highlightsStrong...

Continue reading

Minim Martap Project Development Update

HighlightsSurface miner mobilised to site, with mining operations scheduled to commence in the coming weeks and first production targeted for early Q2, 2026. Updated financial cashflow modelling confirms that the Company’s current cash position along with AFG debt financing fully supports the Company’s CAPEX requirements for Stage 1 as outlined in the DFS, enabling first ore shipment in Q3, 2026, without the need for additional funding from EEA or Afriland. Discussions with CRRC remain ongoing, with current forecasts indicating the first locomotives will arrive at Port of Douala in mid–late Q2, 2026, supporting ore transport from Inland Rail Facility (IRF) to port ahead of shipments commencing in Q3, 2026. Engagement with Camrail continues regarding a potential increase in the Company’s equity interest above the current 9.1%. Off-take...

Continue reading

Dianthus Therapeutics, Inc. Announces Pricing of Upsized $625 Million Underwritten Public Offering

NEW YORK and WALTHAM, Mass., March 10, 2026 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH) (“Dianthus” or the “Company”), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the pricing of its previously announced upsized underwritten public offering of 7,313,582 shares of its common stock at a public offering price per share of $81.00 and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 402,468 shares of its common stock at a public offering price of $80.999 per pre-funded warrant. The pre-funded warrants have an exercise price of $0.001 per share and are exercisable immediately. The aggregate gross proceeds to Dianthus from the offering are expected to be approximately...

Continue reading

Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering

VANCOUVER, British Columbia and BOSTON, March 10, 2026 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced the pricing of its upsized underwritten public offering of 10,526,317 common shares and, in lieu of common shares to certain investors, pre-funded warrants to purchase up to 877,194 common shares pursuant to its existing shelf registration statement. The common shares are being offered at a public offering price of $57.00 per common share and the pre-funded warrants are being offered at a price of $56.9999 per pre-funded warrant. The gross proceeds to Xenon from the offering, before deducting underwriting discounts and commissions...

Continue reading

Liberty Announces Effective Date of Consolidation

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia and WILMINGTON, Mass., March 10, 2026 (GLOBE NEWSWIRE) — Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF), a leading technology provider of AI-based next generation detection solutions for concealed weapons and threats, announces that the Company will implement a consolidation of its common shares in the capital of the Company (the “Shares”) on the basis of forty-five (45) pre-consolidation Shares for every one (1) post-consolidation Share (the “Consolidation”) effective as of March 13, 2026. In accordance with the policies of the TSX Venture Exchange (the “TSXV”), the Consolidation was approved by shareholders of the Company at a special meeting of shareholders held on February...

Continue reading

match.asia Raises Investment from YCP to Scale AI-Driven M&A Marketplace

Singapore, March 10, 2026 (GLOBE NEWSWIRE) — match.asia, a Southeast Asia-focused M&A marketplace, has secured investment from YCP Holdings following strong traction since launching in 2024.Marcus Yeung, CEO & Co-Founder, match.asia The platform has onboarded more than 150 verified sellers across the region. More than two-thirds of opportunities introduced generate investor interest, with over one-third progressing into formal due diligence — results the company attributes to structured data and AI-powered mandate matching. Designed to address inefficiencies in traditional mid-market M&A, particularly in investor identification and outreach, match.asia verifies sellers upfront and introduces opportunities selectively to buyers aligned across sector, size, geography, and transaction structure. Its data-based AI-powered...

Continue reading

Transcontinental Inc. reports on voting results at its Annual and Special Meeting of Shareholders

MONTRÉAL, March 10, 2026 (GLOBE NEWSWIRE) — Transcontinental Inc. (TSX: TCL.A TCL.B) held its Annual and Special Meeting of Shareholders today. All of the candidates proposed as directors were elected and all other resolutions were approved by the applicable majority of the votes cast by the shareholders present or represented by proxy at the meeting by secret ballot as follows:1. Ordinary resolution regarding the election of directors           For Against    Number % of Votes Cast Number % of Votes CastSerge Boulanger 219,346,674 99.65% 779,136 0.35%Jacynthe Côté 218,509,771 99.27% 1,616,039 0.73%Nelson Gentiletti 218,829,776 99.41% 1,296,234 0.59%Isabelle Marcoux 216,169,134 98.20% 3,956,675 1.80%Nathalie Marcoux 207,703,018 94.36% 12,422,992 5.64%Pierre Marcoux 216,101,459 98.17% 4,024,551 1.83%Anna...

Continue reading

Diamondback Energy Announces Pricing of Secondary Common Stock Offering

MIDLAND, Texas, March 10, 2026 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”) announced today the pricing of an underwritten public offering of 11,000,000 shares of its common stock (the “Secondary Offering”) by SGF FANG Holdings, LP (the “Selling Stockholder”). The gross proceeds from the sale of the shares by the Selling Stockholder will be approximately $1.9 billion. Diamondback will not receive any proceeds from the sale of the shares by the Selling Stockholder. The Secondary Offering is expected to close on March 12, 2026, subject to customary closing conditions. The Selling Stockholder has also granted the underwriters a 30-day option to purchase up to an additional 1,650,000 shares of common stock, solely to cover over-allotments. Evercore ISI, Citigroup and J.P. Morgan are acting as joint book-running...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.